BridgeMD
New treatment option for Viral Wart
Official title Intralesional Therapies For Cutaneous Viral Warts: A Comparative Analysis Of Vitamin D3 And Acyclovir
ClinicalTrials.gov ID: NCT07448844
What this study is testing
What is Intralesional Acyclovir?
Intralesional Acyclovir is an investigational medicine, given as an injectable medicine, being studied as a potential treatment for viral wart.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The goal of this clinical trial is to learn if injecting acyclovir (an antiviral drug) or vitamin D3 directly into skin warts works to clear them in people aged 12 and older with common, plantar, flat, or periungual (around the nail) warts. The main questions it aims to answer are: 1.
- Phase 4: studies an already-approved treatment
- Time commitment: about 3 months
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 12 and older
You may be able to join if
- Patients aged 12 years and above with clinically diagnosed cutaneous warts
- Common, plantar, flat, or periungual warts
- Both treatment-naïve patients and those with recalcitrant warts
You likely can't join if
- Pregnant or lactating women
- Immunocompromised patients
- Individuals with history of hypersensitivity to vitamin D3 or acyclovir
- Individuals receiving systemic immunosuppressive or antiviral therapy
- Patients with secondary infection at injection site
- Patients who had received any topical or destructive treatment for wart in previous three months
The study team makes the final eligibility decision.
Where it's taking place
- Rawalpindi, Punjab Province, Pakistan
- Islamabad, Pakistan
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 3 months per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 12 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Rawalpindi, Punjab Province, Pakistan; Islamabad, Pakistan. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.